Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler.

Sorino C, Negri S, Spanevello A, Visca D, Scichilone N.

Eur J Intern Med. 2020 Feb 26. pii: S0953-6205(20)30068-6. doi: 10.1016/j.ejim.2020.02.023. [Epub ahead of print] Review.

PMID:
32113944
2.

ERS International Congress, Madrid, 2019: highlights from the Airway Diseases, Asthma and COPD Assembly.

Lahousse L, Bahmer T, Cuevas-Ocaña S, Flajolet P, Mathioudakis AG, McDonnell M, Uller L, Schleich F, Dortas Junior S, Idzko M, Singh D, Ricciardolo FLM, Adcock IM, Usmani O, Spanevello A, Bonvini SJ.

ERJ Open Res. 2020 Feb 17;6(1). pii: 00341-2019. doi: 10.1183/23120541.00341-2019. eCollection 2020 Jan. Review.

3.

Exercise Capacity and Comorbidities in Patients With Obstructive Sleep Apnea.

Vitacca M, Paneroni M, Braghiroli A, Balbi B, Aliani M, Guido P, Fanfulla F, Pertosa M, Ceriana P, Zampogna E, Raccanelli R, Sarno N, Spanevello A, Maniscalco M, Malovini A, Ambrosino N.

J Clin Sleep Med. 2020 Jan 31. doi: 10.5664/jcsm.8258. [Epub ahead of print]

PMID:
32003743
4.

The pleura and the endocrine system.

Sorino C, Negri S, Spanevello A, Feller-Kopman D.

Eur J Intern Med. 2020 Feb;72:34-37. doi: 10.1016/j.ejim.2019.12.034. Epub 2020 Jan 7. Review.

PMID:
31918926
5.

Cardio-Respiratory ICF sets for inpatient rehabilitation: from theory to practice.

Giardini A, Traversi E, Paneroni M, Mazza A, Passantino A, Traversoni S, Pedretti R, Spanevello A, Vitacca M; ICF Cardio-Respiratory Maugeri group.

Eur J Phys Rehabil Med. 2019 Dec 3. doi: 10.23736/S1973-9087.19.05384-X. [Epub ahead of print] No abstract available.

6.

Implementation of a real-world based ICF set for the rehabilitation of respiratory diseases: a pilot study.

Vitacca M, Giardini A, Corica G, Ceriana P, Carone M, Balbi B, Fracchia C, Maniscalco M, Fanfulla F, Sarno N, Raccanelli R, Traversoni S, Spanevello A.

Minerva Med. 2019 Oct 14. doi: 10.23736/S0026-4806.19.06261-X. [Epub ahead of print]

7.

Pulmonary rehabilitation: promising nonpharmacological approach for treating asthma?

Zampogna E, Spanevello A, Visca D.

Curr Opin Allergy Clin Immunol. 2020 Feb;20(1):80-84. doi: 10.1097/ACI.0000000000000597.

PMID:
31633568
8.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

Borisov S, Danila E, Maryandyshev A, Dalcolmo M, Miliauskas S, Kuksa L, Manga S, Skrahina A, Diktanas S, Codecasa LR, Aleksa A, Bruchfeld J, Koleva A, Piubello A, Udwadia ZF, Akkerman OW, Belilovski E, Bernal E, Boeree MJ, Cadiñanos Loidi J, Cai Q, Cebrian Gallardo JJ, Dara M, Davidavičienė E, Forsman LD, De Los Rios J, Denholm J, Drakšienė J, Duarte R, Elamin SE, Escobar Salinas N, Ferrarese M, Filippov A, Garcia A, García-García JM, Gaudiesiute I, Gavazova B, Gayoso R, Gomez Rosso R, Gruslys V, Gualano G, Hoefsloot W, Jonsson J, Khimova E, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Marchese V, Martínez Robles E, Matteelli A, Mazza-Stalder J, Moschos C, Muñoz-Torrico M, Mustafa Hamdan H, Nakčerienė B, Nicod L, Nieto Marcos M, Palmero DJ, Palmieri F, Papavasileiou A, Payen MC, Pontarelli A, Quirós S, Rendon A, Saderi L, Šmite A, Solovic I, Souleymane MB, Tadolini M, van den Boom M, Vescovo M, Viggiani P, Yedilbayev A, Zablockis R, Zhurkin D, Zignol M, Visca D, Spanevello A, Caminero JA, Alffenaar JW, Tiberi S, Centis R, D'Ambrosio L, Pontali E, Sotgiu G, Migliori GB.

Eur Respir J. 2019 Dec 19;54(6). pii: 1901522. doi: 10.1183/13993003.01522-2019. Print 2019 Dec.

PMID:
31601711
9.

Correction to: When kidneys and lungs suffer together.

Sorino C, Scichilone N, Pedone C, Negri S, Visca D, Spanevello A.

J Nephrol. 2020 Feb;33(1):187. doi: 10.1007/s40620-019-00643-w.

PMID:
31529293
10.

Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis.

Zampogna E, Centis R, Negri S, Fiore E, Cherubino F, Pignatti P, Heffler E, Canonica GW, Sotgiu G, Saderi L, Migliori GB, Spanevello A, Visca D.

J Asthma. 2019 Aug 13:1-7. doi: 10.1080/02770903.2019.1646271. [Epub ahead of print]

PMID:
31317799
11.

Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity.

Zampogna E, Paneroni M, Cherubino F, Pignatti P, Rudi M, Casu G, Vitacca M, Spanevello A, Visca D.

Respir Care. 2019 Dec;64(12):1523-1530. doi: 10.4187/respcare.06761. Epub 2019 Jul 16.

PMID:
31311850
12.

Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.

Pignatti P, Visca D, Cherubino F, Zampogna E, Lucini E, Saderi L, Sotgiu G, Spanevello A.

Respir Res. 2019 Jul 10;20(1):145. doi: 10.1186/s12931-019-1111-1.

13.

Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD.

Zanini A, Crisafulli E, D'Andria M, Gregorini C, Cherubino F, Zampogna E, Azzola A, Spanevello A, Schiavone N, Chetta A.

Respir Care. 2019 Oct;64(10):1261-1269. doi: 10.4187/respcare.06694. Epub 2019 Jul 3.

PMID:
31270178
14.

Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study.

Contoli M, Baraldo S, Conti V, Gnesini G, Marku B, Casolari P, Scrigner P, Morelli P, Saetta M, Spanevello A, Papi A.

Respirology. 2020 Jan;25(1):80-88. doi: 10.1111/resp.13607. Epub 2019 Jun 28.

15.

[Linking the ICF codes to clinical real-life assessments: the challenge of the transition from theory to practice].

Giardini A, Vitacca M, Pedretti R, Nardone A, Chiovato L, Spanevello A.

G Ital Med Lav Ergon. 2019 May;41(2):78-104. Italian.

16.

Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases.

Agache I, Annesi-Maesano I, Bonertz A, Branca F, Cant A, Fras Z, Ingenrieth F, Namazova-Baranova L, Odemyr M, Spanevello A, Vieths S, Yorgancioglu A, Alvaro-Lozano M, Barber Hernandez D, Chivato T, Del Giacco S, Diamant Z, Eguiluz-Gracia I, van Wijk RG, Gevaert P, Graessel A, Hellings P, Hoffmann-Sommergruber K, Jutel M, Lau S, Lauerma A, Maria Olaguibel J, O'Mahony L, Ozdemir C, Palomares O, Pfaar O, Sastre J, Scadding G, Schmidt-Weber C, Schmid-Grendelmeier P, Shamji M, Skypala I, Spinola M, Spranger O, Torres M, Vereda A, Bonini S.

Allergy. 2019 Nov;74(11):2064-2076. doi: 10.1111/all.13856. Epub 2019 Jun 2.

PMID:
31070805
17.

Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018.

Seys SF, Quirce S, Agache I, Akdis CA, Alvaro-Lozano M, Antolín-Amérigo D, Bjermer L, Bobolea I, Bonini M, Bossios A, Brinkman P, Bush A, Calderon M, Canonica W, Chanez P, Couto M, Davila I, Del Giacco S, Del Pozo V, Erjefält JS, Gevaert P, Hagedoorn P, G Heaney L, Heffler E, Hellings PW, Jutel M, Kalayci O, Kurowski MM, Loukides S, Nair P, Palomares O, Polverino E, Sanchez-Garcia S, Sastre J, Schwarze J, Spanevello A, Ulrik CS, Usmani O, Van den Berge M, Vasakova M, Vijverberg S, Diamant Z.

Allergy. 2019 Nov;74(11):2244-2248. doi: 10.1111/all.13843. Epub 2019 May 31. No abstract available.

PMID:
31021446
18.

Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study.

Zampogna E, Spanevello A, Lucioni AM, Facchetti C, Sotgiu G, Saderi L, Ambrosino N, Visca D.

Respir Med. 2019 Apr;150:95-100. doi: 10.1016/j.rmed.2019.02.017. Epub 2019 Mar 1.

PMID:
30961958
19.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring.

Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3.

20.

Research highlights from the 2018 European Respiratory Society International Congress: airway disease.

Schleich F, Bikov A, Mathioudakis AG, McDonnell M, Andersson C, Bonini M, Uller L, Idzko M, Singh D, Lopez-Campos JL, Bossios A, Adcock IM, Usmani O, Spanevello A, Bonvini SJ.

ERJ Open Res. 2019 Mar 18;5(1). pii: 00225-2018. doi: 10.1183/23120541.00225-2018. eCollection 2019 Feb. Review.

21.

Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae.

Visca D, Zampogna E, Sotgiu G, Centis R, Saderi L, D'Ambrosio L, Pegoraro V, Pignatti P, Muňoz-Torrico M, Migliori GB, Spanevello A.

Eur Respir J. 2019 Mar 14;53(3). pii: 1802184. doi: 10.1183/13993003.02184-2018. Print 2019 Mar. No abstract available.

PMID:
30872556
22.

When kidneys and lungs suffer together.

Sorino C, Scichilone N, Pedone C, Negri S, Visca D, Spanevello A.

J Nephrol. 2019 Oct;32(5):699-707. doi: 10.1007/s40620-018-00563-1. Epub 2018 Dec 6. Review. Erratum in: J Nephrol. 2019 Sep 16;:.

PMID:
30523563
23.

The new frontiers of rehabilitation medicine in people with chronic disabling illnesses.

Scrutinio D, Giardini A, Chiovato L, Spanevello A, Vitacca M, Melazzini M, Giorgi G.

Eur J Intern Med. 2019 Mar;61:1-8. doi: 10.1016/j.ejim.2018.10.019. Epub 2018 Oct 30. Review.

24.

Relationship between diabetes and respiratory diseases-Clinical and therapeutic aspects.

Visca D, Pignatti P, Spanevello A, Lucini E, La Rocca E.

Pharmacol Res. 2018 Nov;137:230-235. doi: 10.1016/j.phrs.2018.10.008. Epub 2018 Oct 9. Review.

PMID:
30312663
25.

Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018.

Satia I, Badri H, Lahousse L, Usmani OS, Spanevello A.

J Thorac Dis. 2018 Sep;10(Suppl 25):S2992-S2997. doi: 10.21037/jtd.2018.08.23. No abstract available.

26.

Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta2-agonists formulations in chronic obstructive pulmonary disease.

Pirina P, Foschino Barbaro MP, Paleari D, Spanevello A.

Respir Med. 2018 Oct;143:74-81. doi: 10.1016/j.rmed.2018.08.013. Epub 2018 Aug 28.

27.

Is there a role for biomarkers in pulmonary rehabilitation?

Maniscalco M, Paris D, Carone M, Spanevello A, Vitacca M, Motta A.

Biomark Med. 2018 Oct;12(10):1069-1072. doi: 10.2217/bmm-2018-0219. Epub 2018 Sep 7. No abstract available.

PMID:
30191733
28.

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.

Borisov SE, D'Ambrosio L, Centis R, Tiberi S, Dheda K, Alffenaar JW, Amale R, Belilowski E, Bruchfeld J, Canneto B, Denholm J, Duarte R, Esmail A, Filippov A, Davies Forsman L, Gaga M, Ganatra S, Igorevna GA, Lazaro Mastrapa B, Manfrin V, Manga S, Maryandyshev A, Massard G, González Montaner P, Mullerpattan J, Palmero DJ, Pontarelli A, Papavasileiou A, Pontali E, Romero Leyet R, Spanevello A, Udwadia ZF, Viggiani P, Visca D, Sotgiu G, Migliori GB.

J Infect. 2019 Jan;78(1):35-39. doi: 10.1016/j.jinf.2018.08.003. Epub 2018 Aug 7.

PMID:
30096332
30.

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review.

Pontali E, Sotgiu G, Tiberi S, Tadolini M, Visca D, D'Ambrosio L, Centis R, Spanevello A, Migliori GB.

Eur Respir J. 2018 Jul 4;52(1). pii: 1800934. doi: 10.1183/13993003.00934-2018. Print 2018 Jul. No abstract available.

31.

Tuberculosis elimination: where are we now?

Matteelli A, Rendon A, Tiberi S, Al-Abri S, Voniatis C, Carvalho ACC, Centis R, D'Ambrosio L, Visca D, Spanevello A, Battista Migliori G.

Eur Respir Rev. 2018 Jun 13;27(148). pii: 180035. doi: 10.1183/16000617.0035-2018. Print 2018 Jun 30. Review.

32.

Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD.

Donner CF, Amaducci S, Bacci E, Baldacci S, Bartoli ML, Beghi GM, Benfante A, Brighindi S, Casali L, Castiglia D, Cazzola M, Celi A, Cianchetti S, Colombo G, Crimi C, Dente FL, Di Maria G, Di Maria A, Latorre M, Lavorini F, Maio S, Mannini C, Messina R, Paggiaro PL, Pignatti P, Price D, Scichilone N, Simoni M, Spanevello A, Stagno d'Alcontres M, Tan S, Torchio R, Viegi G, Visca D, Wouters EFM, Yu Hui Xin S.

Monaldi Arch Chest Dis. 2018 Feb 2;88(1):886. doi: 10.4081/monaldi.2018.886.

33.

Research highlights from the 2017 ERS International Congress: airway diseases in focus.

Andersson C, Bonvini SJ, Horvath P, Marquez E, Satia I, Kirkham P, Schleich F, Idzko M, Gosens R, Lopez-Campos JL, Bossios A, Usmani O, Spanevello A, Adcock IM, Mathioudakis AG.

ERJ Open Res. 2018 Mar 13;4(1). pii: 00163-2017. doi: 10.1183/23120541.00163-2017. eCollection 2018 Jan. Review.

34.

Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.

Pontali E, Visca D, Centis R, D'Ambrosio L, Spanevello A, Migliori GB.

Curr Opin Pulm Med. 2018 May;24(3):244-252. doi: 10.1097/MCP.0000000000000477. Review.

PMID:
29470252
35.

Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use.

Pignatti P, Visca D, Leoni V, Zampogna E, Cherubino F, Sotgiu G, Lucini E, Spanevello A.

Clin Respir J. 2018 May;12(5):1989-1990. doi: 10.1111/crj.12747. Epub 2017 Dec 21. No abstract available.

PMID:
29193790
36.

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD.

Contoli M, Pauletti A, Rossi MR, Spanevello A, Casolari P, Marcellini A, Forini G, Gnesini G, Marku B, Barnes N, Rizzi A, Curradi G, Caramori G, Morelli P, Papi A.

Eur Respir J. 2017 Oct 5;50(4). pii: 1700451. doi: 10.1183/13993003.00451-2017. Print 2017 Oct.

37.

Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients.

Contoli M, Campo G, Pavasini R, Marchi I, Pauletti A, Balla C, Spanevello A, Ferrari R, Papi A.

Eur J Intern Med. 2018 Jan;47:82-86. doi: 10.1016/j.ejim.2017.08.016. Epub 2017 Aug 15.

PMID:
28821412
38.

Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple?

Balbi B, Marcassa C, Pisani F, Corica G, Spanevello A.

Monaldi Arch Chest Dis. 2017 May 18;87(1):818. doi: 10.4081/monaldi.2017.818.

39.

Is bronchodilator the correct treatment for COPD subjects before EBUS?

Leoni V, Pignatti P, Visca D, Spanevello A.

J Thorac Dis. 2017 May;9(Suppl 5):S410-S413. doi: 10.21037/jtd.2017.03.142. Review.

40.

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D'Ambrosio L, Centis R, Sotgiu G, Tiberi S, Alffenaar JW, Maryandyshev A, Belilovski E, Ganatra S, Skrahina A, Akkerman O, Aleksa A, Amale R, Artsukevich J, Bruchfeld J, Caminero JA, Carpena Martinez I, Codecasa L, Dalcolmo M, Denholm J, Douglas P, Duarte R, Esmail A, Fadul M, Filippov A, Davies Forsman L, Gaga M, Garcia-Fuertes JA, García-García JM, Gualano G, Jonsson J, Kunst H, Lau JS, Lazaro Mastrapa B, Teran Troya JL, Manga S, Manika K, González Montaner P, Mullerpattan J, Oelofse S, Ortelli M, Palmero DJ, Palmieri F, Papalia A, Papavasileiou A, Payen MC, Pontali E, Robalo Cordeiro C, Saderi L, Sadutshang TD, Sanukevich T, Solodovnikova V, Spanevello A, Topgyal S, Toscanini F, Tramontana AR, Udwadia ZF, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2017 May 21;49(5). pii: 1700387. doi: 10.1183/13993003.00387-2017. Print 2017 May.

41.

A European Respiratory Society technical standard: exhaled biomarkers in lung disease.

Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, Amann A, Antus B, Baraldi E, Bikov A, Boots AW, Bos LD, Brinkman P, Bucca C, Carpagnano GE, Corradi M, Cristescu S, de Jongste JC, Dinh-Xuan AT, Dompeling E, Fens N, Fowler S, Hohlfeld JM, Holz O, Jöbsis Q, Van De Kant K, Knobel HH, Kostikas K, Lehtimäki L, Lundberg J, Montuschi P, Van Muylem A, Pennazza G, Reinhold P, Ricciardolo FLM, Rosias P, Santonico M, van der Schee MP, van Schooten FJ, Spanevello A, Tonia T, Vink TJ.

Eur Respir J. 2017 Apr 26;49(4). pii: 1600965. doi: 10.1183/13993003.00965-2016. Print 2017 Apr.

42.

The Barthel index-dyspnea a tool for respiratory rehabilitation: reply to the letter by Chuang [Letter of clarification].

Carone M, Vitacca M, Paneroni M, Baiardi P, Spanevello A, Bertolotti G.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 8;12:813-815. doi: 10.2147/COPD.S130991. eCollection 2017. No abstract available.

43.

Assembly 5: airway diseases: Meet the Assemblies.

Spanevello A.

Breathe (Sheff). 2017 Mar;13(1):59-60. doi: 10.1183/20734735.018516.

44.

Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.

Griffo R, Spanevello A, Temporelli PL, Faggiano P, Carone M, Magni G, Ambrosino N, Tavazzi L; SUSPIRIUM Investigators.

Eur J Prev Cardiol. 2017 Apr;24(6):567-576. doi: 10.1177/2047487316687425. Epub 2017 Jan 9.

PMID:
28067533
45.

Classifying new anti-tuberculosis drugs: rationale and future perspectives.

Tiberi S, Scardigli A, Centis R, D'Ambrosio L, Muñoz-Torrico M, Salazar-Lezama MÁ, Spanevello A, Visca D, Zumla A, Migliori GB, Caminero Luna JA.

Int J Infect Dis. 2017 Mar;56:181-184. doi: 10.1016/j.ijid.2016.10.026. Epub 2016 Nov 3.

46.

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?

Muñoz-Torrico M, Rendon A, Centis R, D'Ambrosio L, Fuentes Z, Torres-Duque C, Mello F, Dalcolmo M, Pérez-Padilla R, Spanevello A, Migliori GB.

J Bras Pneumol. 2016 Sep-Oct;42(5):374-385. doi: 10.1590/S1806-37562016000000226. Review. English, Portuguese.

47.

Recent developments in the diagnosis and management of tuberculosis.

Sulis G, Centis R, Sotgiu G, D'Ambrosio L, Pontali E, Spanevello A, Matteelli A, Zumla A, Migliori GB.

NPJ Prim Care Respir Med. 2016 Nov 3;26:16078. doi: 10.1038/npjpcrm.2016.78. Review.

48.

Shortened questionnaires to assess anxiety and depression during in-hospital rehabilitation: clinical validation and cutoff scores.

Bertolotti G, Moroni L, Burro R, Spanevello A, Pedretti RF, Giorgetti G.

Neuropsychiatr Dis Treat. 2016 Oct 12;12:2627-2633. eCollection 2016.

49.

Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough.

Pignatti P, Spanevello A.

Ann Transl Med. 2016 Sep;4(18):357. No abstract available.

50.

Development of a Barthel Index based on dyspnea for patients with respiratory diseases.

Vitacca M, Paneroni M, Baiardi P, De Carolis V, Zampogna E, Belli S, Carone M, Spanevello A, Balbi B, Bertolotti G.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 7;11:1199-206. doi: 10.2147/COPD.S104376. eCollection 2016.

Supplemental Content

Loading ...
Support Center